Notable Runner: Isoray Inc (TSE:ISR): Institutional Investors Aren’t Crazy About It

November 16, 2016 - By Clifton Ray   ·   0 Comments

Notable Runner: Isoray Inc (TSE:ISR): Institutional Investors Aren't Crazy About It

Sentiment for Isoray Inc (TSE:ISR)

Isoray Inc (TSE:ISR) institutional sentiment increased to 0.63 in 2016 Q2. Its up 0.06, from 0.57 in 2016Q1. The ratio improved, as 5 funds increased or opened new positions, while 8 decreased and sold stock positions in Isoray Inc. The funds in our partner’s database now own: 4.24 million shares, down from 4.40 million shares in 2016Q1. Also, the number of funds holding Isoray Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 1 Reduced: 7 Increased: 2 New Position: 3.

Wi2Wi Corporation is an integrator and maker of wireless technology solutions. The company has a market cap of $6.76 million. The Firm designs, makes and markets system in package and modular products for wireless applications around the world. It currently has negative earnings. The Firm provides connectivity solutions, precision timing devices, frequency control products, and radio frequency and microwave filters.

It is down 6.00% since October 17, 2016 and is uptrending. It has outperformed by 1.31% the S&P500.

Crestwood Advisors Llc holds 0.01% of its portfolio in Wi2Wi Corp for 54,824 shares. Ifrah Financial Services Inc. owns 30,000 shares or 0.01% of their US portfolio. Moreover, Auxier Asset Management has 0% invested in the company for 14,218 shares. The North Carolina-based Bank Of America Corp De has invested 0% in the stock. Bank Of New York Mellon Corp, a New York-based fund reported 85,652 shares.#img1#

ISR Company Profile

IsoRay, Inc., incorporated on July 13, 1983, is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, makes and sells isotope medical products and devices for the treatment of cancer and other malignant diseases. The Firm is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor.

More notable recent Wi2Wi Corp (TSE:ISR) news were published by: Marketwired.com which released: “Wi2Wi Corp. Comments on Market Activity” on July 22, 2016, also Marketwired.com with their article: “Wi2Wi Corporation Announces Results for the Quarter Ending September 30, 2016” published on November 14, 2016, Businesswire.com published: “Wi2Wi Enters into Asset Purchase Agreement with Precision Devices, Inc.” on October 03, 2014. More interesting news about Wi2Wi Corp (TSE:ISR) were released by: Law360.com and their article: “SEC Sues Interinvest For $17M Conflicted Penny Stock Buys” published on June 17, 2015 as well as Marketwired.com‘s news article titled: “Madison Capital Corporation Announces Proposed Qualifying Transaction” with publication date: November 21, 2013.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>